Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Down 33.7% in May

Dominari Holdings Inc. (NASDAQ:DOMH) saw a significant drop in short interest in May. As of May 29th, there was short interest totaling 349,871 shares, a drop of 33.7% from the May 14th total of 527,421 shares. Based on an average daily volume of 141,717 shares, the days-to-cover ratio is currently 2.5 days. Approximately 3.5% of the company’s stock are short sold.

Dominari Trading Down 1.6%

Shares of Dominari stock opened at $3.15 on Thursday. The business’s fifty day simple moving average is $3.18 and its 200 day simple moving average is $3.57. The firm has a market capitalization of $71.22 million, a P/E ratio of -0.78 and a beta of 0.80. Dominari has a 12 month low of $2.68 and a 12 month high of $8.40.

Dominari (NASDAQ:DOMH) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($2.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.17) by ($1.94). The business had revenue of $35.81 million for the quarter, compared to the consensus estimate of $35.81 million. Dominari had a negative return on equity of 206.20% and a negative net margin of 31.37%.

Dominari Dividend Announcement

The firm also recently declared a special dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were issued a dividend of $0.31 per share. The ex-dividend date was Friday, May 15th.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded Dominari from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

Institutional Trading of Dominari

A number of hedge funds have recently bought and sold shares of DOMH. Creek Drive Management Group LLC bought a new stake in Dominari during the fourth quarter worth $1,861,000. Two Sigma Investments LP purchased a new stake in Dominari in the third quarter worth $771,000. Renaissance Technologies LLC purchased a new stake in Dominari in the fourth quarter worth $412,000. Connective Capital Management LLC increased its position in Dominari by 26.2% in the third quarter. Connective Capital Management LLC now owns 335,273 shares of the company’s stock worth $2,377,000 after buying an additional 69,545 shares during the last quarter. Finally, Susquehanna Advisors Group Inc. purchased a new stake in Dominari in the fourth quarter worth $182,000. 42.48% of the stock is currently owned by institutional investors.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2.